ID: ALA5268823

Max Phase: Preclinical

Molecular Formula: C20H16FNO2

Molecular Weight: 321.35

Associated Items:

Representations

Canonical SMILES:  O=C(O)c1cc(F)cc(NCc2ccc(-c3ccccc3)cc2)c1

Standard InChI:  InChI=1S/C20H16FNO2/c21-18-10-17(20(23)24)11-19(12-18)22-13-14-6-8-16(9-7-14)15-4-2-1-3-5-15/h1-12,22H,13H2,(H,23,24)

Standard InChI Key:  WLSNXCFZVAKOMB-UHFFFAOYSA-N

Associated Targets(Human)

Peroxisome proliferator-activated receptor alpha 9197 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 321.35Molecular Weight (Monoisotopic): 321.1165AlogP: 4.80#Rotatable Bonds: 5
Polar Surface Area: 49.33Molecular Species: ACIDHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 4.46CX Basic pKa: 2.63CX LogP: 4.46CX LogD: 1.76
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.71Np Likeness Score: -0.96

References

1. Lee JJ, Hu Z, Wang YA, Nath D, Liang W, Cui Y, Ma JX, Duerfeldt AS..  (2023)  Design, Synthesis, and Structure-Activity Relationships of Biaryl Anilines as Subtype-Selective PPAR-alpha Agonists.,  14  (6): [PMID:37312852] [10.1021/acsmedchemlett.3c00056]

Source